近日，经湖南省药品监督管理局进行资料审查与现场评估，湖南美媛本草生物工程有限公司成为湖南省 首家获准开展化妆品个性化服务试点工作的企业，标志着化妆品个性化服务创新模式在湖南正式进入实 践阶段，消费者在长沙即可体验"量身定制"的化妆品服务。 化妆品个性化服务试点是深化"放管服"改革、激发产业创新活力的重要举措。湖南省首家试点门店的落 地，不仅为消费者带来了更精准、更灵活的美妆体验选择，也为全省化妆品产业转型升级与商业模式创 新提供了实践样本。 下一步，湖南省药品监督管理局将持续加强对试点工作的监督与指导，总结推广经验，推动化妆品产业 规范、健康、高质量发展。(肖帅) 根据《国家药监局综合司关于开展化妆品个性化服务第二阶段试点工作的通知》（药监综妆〔2025〕58 号）的统一部署，湖南省积极推进化妆品监管改革创新。试点工作允许符合条件的化妆品备案人在其指 定门店，根据消费者的个性化需求，现场对已备案的普通化妆品进行小批量、简单的调配与分装，旨在 满足市场多元化需求，探索行业高质量发展新路径。 试点企业湖南美媛本草生物工程有限公司成立于1990年，坐落于长沙国家高新区生物医药园，是一家面 向全球，集医疗器械、化妆品 ...

春节悦己消费潮涌 浙江创新监管护航"美丽年味" 更关键的是"网络神秘买样实验室"——工作人员模拟普通消费者购买可疑产品，靶向抽检，问题产品检 出率大幅提升。 另外，浙江省药品监督管理局牵头建成国家药品监督管理局药品智慧监管创新应用项目"数治美妆"，并 建立浙沪皖跨省监管协作机制，风险信息实时预警。针对电商平台，印发《化妆品网络经营质量管理工 作指引》，指导淘天集团建立入网"智慧审核"通道。 改革赋能：让创新跑出"加速度" 在监管守住安全底线的同时，如何为企业创新腾挪空间？浙江给出的答案是：以改革提效能，以服务促 发展。 "彩妆产品通常涉及很多颜色，如一款指甲油可能有几十乃至上百个色号。以前，每一个颜色都需要分 开备案检测，费用高、周期长。"浙江科维思科技有限公司负责人金继月表示，金华市实施的同系列产 品优化备案改革落地后，备案检测的费用和时间成本大幅降低。 这项改革正是浙江省药品监督管理局备案"惠企赋能"改革的缩影。在统一长三角区域备案标准的基础 上，浙江推行备案"优审快办"，对备案质量高的企业开通快速通道，既提升了备案质量，又缩短了备案 周期。 中新网杭州2月15日电(祝晓艳 潘沁文)今年春节，在"00后" ...

Group 1 - The article discusses tax deduction policies for advertising and business promotion expenses for specific industries, including cosmetics manufacturing, beverage manufacturing (excluding alcoholic beverages), and pharmaceutical manufacturing, allowing a deduction of up to 30% of annual sales revenue from January 1, 2026, to December 31, 2027 [3][4]. - Expenses exceeding the 30% limit can be carried forward to future tax years for deduction [4]. - Related enterprises can allocate advertising and business promotion expenses through agreements, allowing one party to deduct eligible expenses while the other party can exclude these allocated expenses from their deduction limits [4].

这套体系如同精密咬合的齿轮，不仅推动"小金珠"从新品迅速跃升为超级爆品，更标志着林清轩完成了从"创始人驱动"向"组织驱动"的关键跃迁。 （来源：化妆品观察 品观） "从'上市慢慢做量'到'上市即上量'，林清轩证明了'超级大单品'是可以被复制的。"林清轩创始人孙来春在采访中如是说。 2025 年7月推出的「小金珠」嘭弹水，至今年1月26日不仅实现累计售出 535万瓶、狂揽3亿元的亮眼成绩；更连续多月超越兰蔻、赫莲娜等国际大牌，稳 坐天猫爽肤水类目榜单 TOP1、抖音精华水超值爆款榜单 TOP1，成为国货高端护肤新晋爆品。 在孙来春看来，这一现象级成绩并非偶然的市场红利或流量风口的产物，而是组织能力进化的"必然结果"。 其背后，既有林清轩23年深耕天然植物护肤、近14年专注高山红山茶花活性成分研发的深厚积淀，更源于过去五年系统性构建的"集成化组织力体系"—— 一套覆盖产品研发、渠道运营到品牌营销的高效协同机制。 引爆路径： "线下种草 + 创始人 IP " 「小金珠」嘭弹水的崛起，打破了当下美妆行业对线上流量的路径依赖，走出了一条以线下为根基、全渠道协同的全新爆品打造路径，成为国货高端护肤 破局国际大牌的典型样本 ...

Group 1 - The core viewpoint of the articles emphasizes the importance of regulating excessive packaging in the market to promote green and low-carbon consumption, especially as the Spring Festival approaches [1][3] - The Urumqi Market Supervision Administration is conducting a special enforcement action focused on excessive packaging, targeting products such as tea, cosmetics, food, and alcohol [1] - Enforcement actions include inspections of large supermarkets and cosmetic stores, checking compliance with documentation requirements and identifying violations related to excessive packaging [1] Group 2 - The administration is using various methods such as supervision, guidance, and public exposure to strengthen regulatory enforcement against excessive packaging [1] - The agency is educating consumers about the harms of excessive packaging and encouraging them to resist it, promoting a green consumption philosophy [1] - Future plans include maintaining ongoing regulation of excessive packaging, enhancing policy promotion, and ensuring consumer rights are protected during the festive shopping surge [3]

DATA SPECIALITY REVIEW BENCHMARKING 知行数据观察 卸妆品类 知行合一集团 经营使命 以数为据，不让企业走弯路 尊重专业，凡是彻底 核心价值观 企业精神 对标找差距，复盘取机会 经营理念 客户的生意就是知行人的命 行业宏观市场调研 卸妆行业定义及分类 卸妆产品是专门用于清除面部及眼唇等部位彩妆、防晒霜、油脂性污染物和多余皮脂的清洁类化妆品，核心功能是通过特定配方 体系溶解或乳化附着于皮肤表面的脂溶性物质，同时兼顾温和性，避免过度刺激或损伤皮肤屏障。根据国家标准 GB/T 35914- 2018《卸妆油（液、乳、膏、霜）》，卸妆产品需具备安全、有效、温和的基本特性，适用于不同肤质与妆容类型。 配方体系 油剂体系 乳化体系 水剂体系 特殊体系 代表产品 卸妆油、卸妆膏 卸妆乳、卸妆霜 卸妆水、卸妆啫喱、 卸妆湿巾 水油分离卸妆液 （眼唇专用） 核心成分 油脂（矿物油、植物油、 合成酯）+ 乳化剂 水 + 油 + 乳化剂 水 + 表面活性剂 + 保湿剂 油相 + 水相 + 乳化剂 （不预先混合） 清洁原理 以油溶油 遇水乳化带走污垢 油溶油溶性彩妆，水溶水 溶性污垢，协同工作 表面 ...

Core Viewpoint - The approval of H-share full circulation by the Hong Kong Stock Exchange is expected to enhance stock liquidity and support the company's growth prospects [2]. Recent Events - H-share full circulation was approved on January 29, 2026, allowing 228 million H-shares to be listed and traded, with the announcement made on February 5, 2026 [2]. Institutional Perspectives - In a report dated January 20, 2026, Citi Securities noted that the company plans to launch diversified products in the first quarter of 2026 to support medium to long-term growth objectives [3]. - Goldman Sachs, in a report on February 5, 2026, projected a compound annual growth rate (CAGR) of 23% for sales and 22% for net profit from 2025 to 2027. Additionally, Shenwan Hongyuan's report forecasts a profit growth rate of approximately 35% for 2025 [3]. Operational Status - The company's online channel performance has improved, ranking 4th in the Douyin beauty list in January 2026, indicating enhanced online momentum. Management previously anticipated over 40% year-on-year growth in online sales for the fourth quarter of 2025 [4]. Strategic Advancement - The company opened its first overseas counter in Harbour City, Hong Kong, in October 2025, continuing to advance its "Light and Shadow Aesthetics" internationalization strategy [5]. Company Status - As of February 5, 2026, the company was included in the "2025 Hurun China 500" list with a valuation of 41 billion yuan. Goldman Sachs also added the company to its "Confident Buy" list for the Asia-Pacific region on the same day [6].

Core Viewpoint - NMN (β-Nicotinamide Mononucleotide) is gaining attention in the global health industry for its potential in anti-aging, DNA repair, and metabolic regulation, with significant advancements in regulatory approval and market potential expected by 2025 [1][2]. Industry Overview - The NMN industry has transitioned from laboratory research to commercial viability, with major markets like the US, Japan, Canada, and Australia recognizing its legal status through various regulatory pathways [1][2]. - China is currently the largest producer of NMN raw materials, with leading companies establishing competitive barriers through technological innovation and industry chain layout [2]. NMN Definition and Function - NMN is a direct precursor to NAD+ (Nicotinamide Adenine Dinucleotide), crucial for delaying aging and enhancing physiological functions [3][4]. - Supplementing NMN can rapidly increase NAD+ levels in the body, playing a vital role in anti-aging, cardiovascular health, and metabolic improvement [4]. Synthesis Pathways - NMN supplementation shows significant advantages in NAD+ synthesis pathways compared to other precursors, with the highest conversion efficiency and no known adverse reactions [6][7]. Natural Sources and Supplementation - Natural food sources of NMN are limited, with dietary intake often insufficient to meet effective dosage levels; NMN supplements provide a much higher intake efficiency [8]. Synthesis Technology - The NMN synthesis process has evolved from chemical methods to fully enzymatic methods, focusing on high purity, safety, and environmental sustainability [10][11]. - Leading companies are innovating in fully enzymatic synthesis techniques, creating competitive advantages through patent applications and cost reductions [12]. Development History - The NMN research journey began in 1904, with significant milestones in the 21st century, including pivotal studies confirming NMN's lifespan-extending effects in mice, which attracted global investment [15][14]. Policy Drivers - The regulatory environment for NMN is evolving, with a shift from strict restrictions to cautious openness in major markets, including China, where NMN is moving towards legal status as a health food [17][18]. Demand Drivers - The aging population and increasing anti-aging awareness among younger demographics are driving demand for NMN products, creating a substantial market opportunity [19]. Technological Advancements - Innovations in synthesis, quality testing, and delivery methods are driving the NMN industry towards efficiency and standardization, enhancing product efficacy and user experience [21][22]. Application Areas - NMN is primarily used in health supplements and cosmetics, with potential expansion into pet nutrition, medical health, and agricultural technology [24][28]. Market Size and Growth - The NMN market in China is expected to exceed 30 billion yuan by 2025, driven by regulatory changes and new applications in various sectors [28]. Sales Channels - NMN products are primarily sold through cross-border e-commerce and private channels, with cross-border platforms capturing 60%-70% of the market share [35]. Certification Standards - The "blue hat" certification for health foods in China represents the highest standard for NMN products, indicating safety and compliance [37]. Future Prospects - NMN's potential in cosmetics is significant, with a growing market for anti-aging products and a high compliance level expected to accelerate market growth [51]. Challenges - Despite positive regulatory signals, the NMN industry faces challenges such as exaggerated claims, lack of consumer awareness, and the need for ongoing technological advancements [61][63].

Core Viewpoint - NMN (β-Nicotinamide Mononucleotide) is gaining global attention in the health industry due to its potential in anti-aging, DNA repair, and metabolic regulation, with significant advancements in regulatory approval and market potential expected by 2025 [1][2]. Group 1: NMN Definition and Function - NMN is a direct precursor to NAD+ (Nicotinamide Adenine Dinucleotide), crucial for delaying aging and enhancing physiological functions [3][4]. - Supplementing NMN can rapidly increase NAD+ levels in the body, playing a vital role in anti-aging, cardiovascular health, and cognitive function [4][6]. Group 2: Global Regulatory Landscape - By 2025, NMN's global compliance process is expected to accelerate, with major markets like the US, Japan, Canada, and Australia confirming its legal status through various regulatory pathways [1][2]. - In China, NMN has not yet received approval as a drug or health food, but it has been recognized as a new cosmetic ingredient, laying the groundwork for future regulatory developments [1][17]. Group 3: Market Demand Drivers - The aging population in China is projected to grow significantly, with the elderly population expected to increase from 320 million to 390 million between 2025 and 2030, driving the "silver economy" and demand for anti-aging products [19]. - Younger generations, particularly those born in the 1990s, are increasingly aware of anti-aging needs, creating a dual demand for NMN products [19]. Group 4: Technological Innovations - Continuous innovations in synthesis, quality testing, and delivery methods are driving the NMN industry forward, with full enzyme methods significantly enhancing production efficiency and reducing costs [21][22]. - The establishment of testing standards is raising industry entry barriers, promoting market development [22]. Group 5: Current Market Status - The NMN market in China has been expanding rapidly since its large-scale entry in 2020, with expectations to exceed 3 billion yuan by 2025 [28]. - NMN is primarily used in health supplements (approximately 90% of applications) and cosmetics (10-20%), with potential future applications in pet nutrition, medical health, and agricultural technology [24][28]. Group 6: Sales Channels - NMN products are mainly sold through cross-border e-commerce and private channels, with cross-border e-commerce accounting for 60-70% of the market share [35]. Group 7: Industry Challenges - The NMN industry faces challenges such as exaggerated claims, lack of consumer awareness, and the need for technological iteration, necessitating a focus on compliance and innovation to unlock market potential [61][63].

省药品监管局将以此次节前检查为契机，聚焦危化品管理、消防安全、特种设备运行等重点领域，深入 开展风险隐患大排查大整治，对排查出的问题隐患建立台账、限期整改、闭环管理。督促企业健全日常 安全管理制度，加强员工安全培训和应急演练，持续提升企业本质安全水平。密切关注节日期间药品市 场供应和紧急突发事件处置保障工作，确保常用药、急救药供应不断档、价格不上涨，全力保障群众节 日用药安全。 检查组深入易燃易爆危化品储存区，仔细核查易制毒化学品管理台账与安全防控措施落实情况；在酒精 储罐区，重点检查防泄漏报警装置运行状态及应急处置准备工作；在化妆品门店，详细查看产品注册备 案手续、进货渠道资质及批发销售记录。针对检查中发现的安全隐患，现场提出明确整改要求，督促立 即整改到位。 本报讯 （记者 郭靓） 2月12日，青海省药品监督管理局深入国药普兰特（青海）药业有限公司、天域 （青海）科技创新有限公司、泰阳国际批发市场等企业，直插生产仓储、批发零售一线，督导检查"两 品一械"安全生产工作，筑牢节日用药安全防线。 ...